Resiliency Intervention for Patients With ALS and Their Care-Partners

NANot yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

June 1, 2026

Study Completion Date

June 30, 2026

Conditions
Amyotrophic Lateral Sclerosis (ALS)Emotional Distress
Interventions
BEHAVIORAL

Resilient Together ALS

This intervention will teach resiliency and coping skills (mindfulness, meaning making, etc) to dyads soon after ALS diagnosis in order to manage distress associated with an ALS diagnosis. These sessions will take place over Zoom with both the person diagnosed with ALS and their primary informal caregiver.

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT06968468 - Resiliency Intervention for Patients With ALS and Their Care-Partners | Biotech Hunter | Biotech Hunter